Mandaviya inaugurates First ESIC Hospital in J&K at Ompora in Srinagar (See 'Corp Brief') IPC signs MoU with Institute of Pharmaceuticals Education, Hajipur (See 'Corp Brief') Modi greets Public Representatives on National Panchayati Raj Day (See 'Corp Brief') Farmer ID & scientific farming models will give agriculture new direction: Chouhan (See 'Corp Brief') NMDC leadership Meets Dantewada Panchayat Heads, Promises Action on Water, Electricity and Roads (See 'Corp Brief') Veep addresses 6th Convocation of AIIMS Rishikesh (See 'Corp Brief') RRM highlights Vital Role of Naval Civilians in Delhi (See 'Corp Brief') IPR - As Constitutional Court under Article 215 of Constitution, appropriate orders are warranted to ensure that its directions are not taken in perfunctory or dismissive manner: HC (See 'Legal Desk') Green Economy: Youth to Play Key Role in India's Sustainability-Driven Growth: MoS (See 'Corp Brief') Scindia lauds BSNL's 'Transformative Performance (See 'Corp Brief') Bharat Coking Coal introduces Cash Discount Scheme for Power Sector Consumers (See 'Corp Brief') Prohibition of Benami Property Transactions Act, 1988 - Mere involvement of cash does not exclude transaction from ambit of benami, particularly where source is undisclosed & transaction is structured to legitimize unaccounted money during demonetization: SAFEMA Tribunal (See 'Legal Desk') Ministry of Steel to hold Open House on Steel Import Issues on Monday (See 'Corp Brief') RM & German counterpart hold bilateral talks in Berlin (See 'Corp Brief') India records Historic Growth in Wind Energy with 6.1 GW addition in 2025-26 (See 'Corp Brief') PMLA - Mere fact that some allegations in predicate FIR were quashed, or that attached property was allegedly purchased before crime period, did not invalidate attachment if companies were recipients of proceeds of crime: SAFEMA (See 'Legal Desk') Agricultural leadership of North India to converge in Lucknow tomorrow (See 'Corp Brief') Railways plants 81.6 lakhs trees in 2025-26 across Zones (See 'Corp Brief') PMLA - If proceeds of crime directly or indirectly obtained or derived out of criminal activity relating to scheduled offence are not traceable, then any other property of accused of equivalent value falls within definition of ‘proceeds of crime': SAFEMA (See 'Legal Desk') MSDE drives skill-led transformation across India's border villages (See 'Corp Brief') Nadda emphasizes 70% of NCD Risk Factors Are Lifestyle-Driven (See 'Corp Brief') Workshop on New Textile Schemes held in Bengaluru (See 'Corp Brief') IPR - Claim for injunction on the ground of breach of confidentiality cannot succeed if plaintiff fails to establish an enforceable confidentiality obligation and has himself publicly disclosed the relevant work: HC (See 'Legal Desk') Farmers need trust and simpler Systems, Not Just Credit: Chouhan (See 'Corp Brief') India's civilisational openness key to future leadership: William Dalrymple (See 'Corp Brief') A&C - Even if arbitration clause expressly names particular official as party-appointed arbitrator, such appointment cannot be sustained if that person is rendered ineligible u/s 12(5) read with Seventh Schedule: HC (See 'Legal Desk') NFRA Circular 2026- lessons to auditor on communication (See CORP EINSICHT) India-ROK Framework for Partnership in Shipbuilding, Shipping and Maritime Logistics (See 'Corp Brief') Food Business Startup Enabler Programme 2.0 conducted (See 'Corp Brief') Policy Support, Startups and Industry participation accelerate Circular Economy Transition (See 'Corp Brief' CCI okays restructuring by Vishakha Renewables and merger with Vishakha Glass (See 'Corp Brief') Scindia highlights historic 16% revenue growth of Department of Posts (See 'Corp Brief') IPR - Scope & clarity of invention are to be ascertained not just from independent claim in isolation, but by reading it together with dependent claims and accompanying drawings: HC (See 'Legal Desk') Samriddh Gram Initiative of India Nominated for WSIS Prizes 2026 (See 'Corp Brief') DARPG to observe 18th Civil Services Day on April 21, 2026 (See 'Corp Brief') IPR - Amended claims that significantly alter original claims transitioning from composition to non-native pancreatic ß cell must be duly considered by Controller independently without being influenced from prior conclusions - YES: HC (See 'Legal Desk') States showcase Best Practices in Digital Health at NHA Chintan Shivir (See 'Corp Brief') PMLA - Cricket betting involves cheating, which constitutes predicate offence under Prevention of Money Laundering Act, 2002, when FIR is registered for scheduled offences such as Section 420 IPC: SAFEMA (See 'Legal Desk') Chouhan reviews Kharif preparedness (See 'Corp Brief') CAQM reviews enforcement actions across NCR (See 'Corp Brief') PMLA - If actual tainted property or proceeds of crime are not traceable or available, authorities are empowered to attach alternative attachable property or untainted property of person involved: SAFEMA (See 'Legal Desk') Corporate laws (Amendment) Bill 2026 - Proposals affecting auditors (See CORP EINSICHT)

IPC signs MoU with Institute of Pharmaceuticals Education, Hajipur

Published: Apr 25, 2026

By TIOLCorplaws News Service

NEW DELHI, APR 25, 2026: UNDER the visionary leadership of Hon'ble Prime Minister Narendra Modi, India continues to strengthen its commitment to ensuring access to quality healthcare and advancing pharmaceutical excellence through strategic institutional collaborations. In line with this vision, the Indian Pharmacopoeia Commission (IPC), Ministry of Health and Family Welfare, Government of India, signed two significant Memoranda of Understanding (MoUs) with the Pharmaceuticals & Medical Devices Bureau of India (PMBI), Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, and the National Institute of Pharmaceutical Education and Research (NIPER), Hajipur, Bihar, an autonomous institution under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India.

The MoU between IPC and PMBI aims to enhance the quality assurance framework for medicines made available through Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs). Under this collaboration, PMBI may submit randomly selected batches of Jan Aushadhi medicines to IPC for quality testing. The partnership will further promote the use of the National Formulary of India (NFI) across Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs) to ensure rational use of medicines. It also seeks to strengthen pharmacovigilance activities by displaying the Pharmacovigilance Programme of India (PvPI) QR code and toll-free helpline number (1800-180-3024) at PMBJKs across the country, thereby encouraging adverse drug reaction (ADR) reporting and improving patient safety. In addition, IPC and PMBI will jointly organize sensitization, awareness, and training programmes for pharmacists and stakeholders on rational use of medicines, pharmacovigilance, ADR reporting tools, and the role of pharmacists in safeguarding public health.

The MoU signed between IPC and NIPER, Hajipur focuses on collaborative research, academic exchange, and capacity building in the area of pharmaceutical science and healthcare products. NIPER Hajipur, an Institute of National Importance, possesses advanced expertise in pharmaceutical analysis, biologics, and clinical research, making it a valuable partner in strengthening pharmacopoeial science and patient safety. This collaboration will include joint research programmes on impurity profiling, including genotoxic impurities such as nitrosamines, and their correlation with adverse drug reaction data to establish evidence-based pharmacopoeial limits. It will also focus on the development of analytical methods, quality control protocols, and reference standards for biologics, biosimilars, and emerging cell and gene therapy products for inclusion in the Indian Pharmacopoeia.

Both institutions will also collaborate in organizing training programmes, workshops, seminars, and conferences, along with faculty exchange initiatives and sharing of advanced analytical instrumentation facilities. Internship and fellowship opportunities for pharmacy graduates and postgraduates, as well as joint publication of research papers, training manuals, and educational materials, will further strengthen scientific engagement and institutional capacity building.

These MoUs reflect IPC's continued efforts to strengthen India's healthcare ecosystem by promoting quality assurance, patient safety, rational use of medicines, and innovation in pharmaceutical standards. Such collaborations will further reinforce India's position as a global leader in pharmaceutical quality, regulatory excellence, and public health advancement.

TIOL CORP SEARCH

TIOL GROUP WEBSITES